SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (311)9/8/1999 10:44:00 PM
From: LLCF  Read Replies (1) | Respond to of 666
 
< In additon I think it will be hard for the FDA to limit the label to transformed disease because they clearly met the clinical endpoints for highly treated patients>

Even given the small trial size??? Or was that all agreed apon between the company and the FDA? Thanks

DAK